Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis

被引：0

作者：

Mancardi, G. L. ^{[1
]}

Sormani, M. P. ^{[1
]}

Gualandi, F. ^{[1
]}

Saiz, A. ^{[2
]}

Carreras, E. ^{[2
]}

Merelli, E. ^{[3
]}

Donelli, A. ^{[3
]}

Lugaresi, A. ^{[4
]}

Di Bartolomeo, P. ^{[5
]}

Rottoli, M. ^{[6
]}

Rambaldi, A. ^{[7
]}

Amato, M. P. ^{[8
]}

Massacesi, L. ^{[8
]}

Vuolo, L. ^{[8
]}

Curro, D. ^{[1
]}

Roccatagliata, L. ^{[1
]}

Filippi, M. ^{[9
]}

Russo, C. ^{[10
]}

Iacopino, P. ^{[10
]}

Saccardi, R. ^{[8
]}

机构：

[1] Univ Genoa, Genoa, Italy

[2] Hosp Clin Barcelona, Barcelona, Spain

[3] Univ Modena & Reggio Emilia, Modena, Italy

[4] Univ Gabriele DAnnunzio, Chieti, Italy

[5] Osped Pescara, Pescara, Italy

[6] OO RR Bergamo, Bergamo, Italy

[7] Osped Riuniti Bergamo, I-24100 Bergamo, Italy

[8] Careggi Univ Hosp, Florence, Italy

[9] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy

[10] Azienda Osped Bianchi Melacrino Morelli, Reggio Di Calabria, Italy

来源：

BONE MARROW TRANSPLANTATION | 2012年 / 47卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S83 / S83

页数：1

共 50 条

[21] Daclizumab phase II trial in relapsing and remitting multiple sclerosis - MRI and clinical results
Rose, J. W.
Burns, J. B.
Bjorklund, J.
Klein, J.
Watt, H. E.
Carlson, G.
NEUROLOGY, 2007, 69 (08) : 785 - 789
[22] Long-term safety results from a phase II, randomised, multicentre trial with ocrelizumab in relapsing-remitting multiple sclerosis
Kappos, L.
Li, D.
Calabresi, P.
O'Connor, P.
Bar-Or, A.
Barkhof, F.
Wells, C.
Leppert, D.
Glanzman, R.
Tinbergen, J.
Hauser, S.
JOURNAL OF NEUROLOGY, 2012, 259 : S65 - S65
[23] Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis: week 96 results of a phase II, randomised, multicentre trial
Kappos, L.
Li, D.
Calabresi, P.
O'Connor, P.
Bar-Or, A.
Barkhof, F.
Yin, M.
Leppert, D.
Glanzmann, R.
Tinbergen, J.
Hauser, S. L.
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S194 - S195
[24] Ocrelizumab in relapsing-remitting multiple sclerosis: brain volume results of a phase II randomised placebo-controlled multicentre trial
Zhao, Y.
Li, D. K. B.
Riddehough, A.
Traboulsee, A.
Masterman, D.
Gilberg, F.
Kappos, L.
Leppert, D.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 446 - 447
[25] Pilot phase I/II clinical trial with autologous mesenchymal stem cells in patients with multiple sclerosis
Karussis, D.
Slavin, S.
Karageorgiou, C.
Kassis, I.
Vaknin-Dembinski, A.
Petrou, P.
Gomori, J.
Gowda-Kurkalli, B.
Ben-Hur, T.
Bulte, J.
HUMAN GENE THERAPY, 2010, 21 (10) : 1436 - 1436
[26] Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
Llufriu, Sara
Sepulveda, Maria
Blanco, Yolanda
Marin, Pedro
Moreno, Beatriz
Berenguer, Joan
Gabilondo, Inigo
Martinez-Heras, Eloy
Sola-Valls, Nuria
Arnaiz, Joan-Albert
Andreu, Enrique J.
Fernandez, Begona
Bullich, Santi
Sanchez-Dalmau, Bernardo
Graus, Francesc
Villoslada, Pablo
Saiz, Albert
PLOS ONE, 2014, 9 (12):
[27] Preliminary results of a phase II trial of montelukast for the treatment of Bronchiolitis obliterans syndrome after HSCT and implications for immunobiology of disease
Williams, K.
Pavletic, S.
Lee, S.
Hakim, F.
Mitchell, S.
Manning-Geist, B. L.
Gea-Banacloche, J.
Comis, L.
Cowen, E.
Baird, K.
Shelhamer, J.
Blacklock-Schuver, B.
Avila, D.
Zulchinski, D.
Gress, R.
BONE MARROW TRANSPLANTATION, 2012, 47 : S61 - S61
[28] Pilot Phase I/II Clinical Trial with Autologous Mesenchymal Stem Cells in Patients with Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Karussis, D.
Karageorgiou, C.
Gowda-Kurkalli, B.
Kassis, I.
Vaknin-Dembinsky, A.
Gomori, J. M.
Bulte, J.
Petrou, P.
Ben-Hur, T.
Slavin, S.
HUMAN GENE THERAPY, 2010, 21 (05) : 650 - 650
[29] Pilot Phase I/II Clinical Trial with Autologous Mesenchymal Stem Cells in Patients with Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Karussis, Dimitrias
Karageorgiou, Clementine
Gowda-Kurkalli, Basan
Vaknin-Dembinsky, Adi
Gomori, John Moshe
Kassis, Ibrahim
Petrou, Panayiota
Bulte, Jeff
Slavin, Shimon
NEUROLOGY, 2010, 74 (09) : A295 - A295
[30] A phase II randomised controlled trial of an early tailored cognitive behavioural therapy based intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): preliminary results
Kiropoulos, L.
Kilpatrick, T.
Kalincek, T.
Churilov, L.
Shuey, N.
Wijeratne, T.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 720 - 720

← 1 2 3 4 5 →